Bimekizumab Long-Term On-Treatment Remission and Associated Sustained Improvements in Quality of Life in Moderate to Severe Plaque Psoriasis Across Five Phase 3/3b Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 10, n. 3, p. s772, 2026. DOI: 10.25251/pkdcct35. Disponível em: https://skin.dermsquared.com/skin/article/view/4229. Acesso em: 12 may. 2026.